These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26226308)

  • 1. An integrated multiplatform bioanalytical strategy for antibody-drug conjugates: a novel case study.
    Myler H; Rangan VS; Wang J; Kozhich A; Cummings JA; Neely R; Dail D; Liu A; Wang B; Vezina HE; Freebern W; Sung MC; Passmore D; Deshpande S; Kempe T; Gu H; Saewert M; Manney A; Lute J; Zambito F; Wong RL; Piccoli SP; Aubry AF; Pillutla R; Arnold M; DeSilva B
    Bioanalysis; 2015; 7(13):1569-82. PubMed ID: 26226308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.
    Roberts SA; Andrews PA; Blanset D; Flagella KM; Gorovits B; Lynch CM; Martin PL; Kramer-Stickland K; Thibault S; Warner G
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):382-91. PubMed ID: 24012707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of bioanalytical measurements using PK-PD modeling and simulation: implications for antibody-drug conjugate development.
    Khot A; Sharma S; Shah DK
    Bioanalysis; 2015; 7(13):1633-48. PubMed ID: 26226312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates.
    Hoofring SA; Lopez R; Hock MB; Kaliyaperumal A; Patel SK; Swanson SJ; Chirmule N; Starcevic M
    Bioanalysis; 2013 May; 5(9):1041-55. PubMed ID: 23641695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalytical approaches for characterizing catabolism of antibody-drug conjugates.
    Saad OM; Shen BQ; Xu K; Khojasteh SC; Girish S; Kaur S
    Bioanalysis; 2015; 7(13):1583-604. PubMed ID: 26226309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics.
    Kaur S; Xu K; Saad OM; Dere RC; Carrasco-Triguero M
    Bioanalysis; 2013 Jan; 5(2):201-26. PubMed ID: 23330562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
    Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K
    Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates.
    Frigerio M; Kyle AF
    Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Conjugated Payload Measurement Using Enzymatic Release of Antibody-Drug Conjugate with Cleavable Linker.
    Rago B; Tumey LN; Wei C; Barletta F; Clark T; Hansel S; Han X
    Bioconjug Chem; 2017 Feb; 28(2):620-626. PubMed ID: 28140559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an integrated series of ligand-binding assays for the quantitative determination of antibody-drug conjugates in biological matrices.
    Myler H; Rangan VS; Kozhich A; Hoffpauir B; Dail D; Cummings J; Saewert M; Manney A; Liu A; Rao C; Wang J; Pillutla R; DeSilva B
    Bioanalysis; 2016 Mar; 8(6):519-31. PubMed ID: 26915587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-drug conjugates nonclinical support: from early to late nonclinical bioanalysis using ligand-binding assays.
    Kumar S; King LE; Clark TH; Gorovits B
    Bioanalysis; 2015; 7(13):1605-17. PubMed ID: 26226310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Two-Step Immunocapture LC/MS/MS Assay for Plasma Stability and Payload Migration Assessment of Cysteine-Maleimide-Based Antibody Drug Conjugates.
    Dong L; Li C; Locuson C; Chen S; Qian MG
    Anal Chem; 2018 May; 90(10):5989-5994. PubMed ID: 29688004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavable linkers in antibody-drug conjugates.
    Bargh JD; Isidro-Llobet A; Parker JS; Spring DR
    Chem Soc Rev; 2019 Aug; 48(16):4361-4374. PubMed ID: 31294429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights on the immunogenicity of antibody-drug conjugates.
    Carrasco-Triguero M
    Bioanalysis; 2015; 7(13):1565-8. PubMed ID: 26226307
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate.
    Sanderson RJ; Hering MA; James SF; Sun MM; Doronina SO; Siadak AW; Senter PD; Wahl AF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):843-52. PubMed ID: 15701875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of attachment site on stability of cleavable antibody drug conjugates.
    Dorywalska M; Strop P; Melton-Witt JA; Hasa-Moreno A; Farias SE; Galindo Casas M; Delaria K; Lui V; Poulsen K; Loo C; Krimm S; Bolton G; Moine L; Dushin R; Tran TT; Liu SH; Rickert M; Foletti D; Shelton DL; Pons J; Rajpal A
    Bioconjug Chem; 2015 Apr; 26(4):650-9. PubMed ID: 25643134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.
    Hock MB; Thudium KE; Carrasco-Triguero M; Schwabe NF
    AAPS J; 2015 Jan; 17(1):35-43. PubMed ID: 25380723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculated conjugated payload from immunoassay and LC-MS intact protein analysis measurements of antibody-drug conjugate.
    Rago B; Clark T; King L; Zhang J; Tumey LN; Li F; Barletta F; Wei C; Leal M; Hansel S; Han X
    Bioanalysis; 2016 Nov; 8(21):2205-2217. PubMed ID: 27682846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo biotransformations of antibody-drug conjugates.
    Tumey LN; Rago B; Han X
    Bioanalysis; 2015; 7(13):1649-64. PubMed ID: 26226313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in antibody-drug conjugate discovery: a bioconjugation and analytical perspective.
    Rao C; Rangan VS; Deshpande S
    Bioanalysis; 2015; 7(13):1561-4. PubMed ID: 26226306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.